Evidence mapPaperPMID 30764699Full record

Trial reportJournal of the American Heart Association2019

Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Julio A Chirinos, Priyanka Bhattacharya, Anupam Kumar, Elizabeth Proto, Prasad Konda, Patrick Segers, Scott R Akers, Raymond R Townsend, Payman Zamani

Open access · goldAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Julio A Chirinos1 Division of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia PA.
Priyanka Bhattacharya1 Division of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia PA.
Anupam Kumar1 Division of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia PA.
Elizabeth Proto2 Division of Cardiovascular Medicine University of Pennsylvania Perelman School of Medicine Philadelphia PA.
Prasad Konda1 Division of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia PA.
Patrick Segers4 Biofluid, Tissue and Solid Mechanics for Medical Applications Ghent University Ghent Belgium.
Scott R Akers3 Department of Radiology Corporal Michael J. Crescenz Veterans Affairs Medical Center Philadelphia PA.
Raymond R Townsend1 Division of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia PA.
Payman Zamani1 Division of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia PA.
Hospital of the University of Pennsylvania · USUniversity of Pennsylvania · USGhent University · BEPhiladelphia VA Medical Center · USVeterans Health Administration · US

Funding

Training Program in Cardiovascular Biology and MedicineT32HL007843 · NHLBI · UNIVERSITY OF PENNSYLVANIA · 1996 to 2025
$3.1M
NCATS NIH HHS UL1 TR000003NCRR NIH HHS UL1 RR024134NHLBI NIH HHS R01 HL121510NHLBI NIH HHS R56 HL124073NHLBI NIH HHS T32 HL007843NIA NIH HHS R21 AG043802
6 · The paper itself

Abstract

Background Heterogeneity in the underlying processes that contribute to heart failure with preserved ejection fraction ( HF p EF ) is increasingly recognized. Diabetes mellitus is a frequent comorbidity in HF p EF , but its impact on left ventricular and arterial structure and function in HF p EF is unknown. Methods and Results We assessed the impact of diabetes mellitus on left ventricular cellular and interstitial hypertrophy (assessed with cardiac magnetic resonance imaging, including T1 mapping pregadolinium and postgadolinium administration), arterial stiffness (assessed with arterial tonometry), and pulsatile arterial hemodynamics (assessed with in-office pressure-flow analyses and 24-hour ambulatory monitoring) among 53 subjects with HF p EF (32 diabetic and 21 nondiabetic subjects). Despite few differences in clinical characteristics, diabetic subjects with HFpEF exhibited a markedly greater left ventricular mass index (78.1 [95% CI , 70.4-85.9] g versus 63.6 [95% CI , 55.8-71.3] g; P=0.0093) and indexed extracellular volume (23.6 [95% CI , 21.2-26.1] mL/m

Indexed as

Ventricular RemodelingAgedBlood PressureComorbidityDiabetes MellitusEchocardiographyFemaleHeart FailureHeart VentriclesHumansMagnetic Resonance Imaging, CineMaleMiddle AgedPrognosisPulse Wave AnalysisStroke VolumeVasodilator Agentsarterial stiffnessdiabetes mellitusheart failure with preserved ejection fractionhemodynamicsleft ventricular hypertrophymagnetic resonance imagingmyocardial fibrosis

Identifiers

PMID30764699
PMCPMC6405670
OpenAlexW2913059531

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.